Venus Remedies Statistics

Total Valuation

Venus Remedies has a market cap or net worth of INR 9.88 billion. The enterprise value is 7.66 billion.

Market Cap	9.88B
Enterprise Value	7.66B

Important Dates

The last earnings date was Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	n/a

Share Statistics

Venus Remedies has 13.37 million shares outstanding. The number of shares has decreased by -0.04% in one year.

Current Share Class	13.37M
Shares Outstanding	13.37M
Shares Change (YoY)	-0.04%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	30.05%
Owned by Institutions (%)	1.10%
Float	6.37M

Valuation Ratios

The trailing PE ratio is 12.95.

PE Ratio	12.95
Forward PE	n/a
PS Ratio	1.41
PB Ratio	1.66
P/TBV Ratio	2.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	10.05
EV / Sales	1.09
EV / EBITDA	6.94
EV / EBIT	7.99
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.02
Debt / EBITDA	0.13
Debt / FCF	n/a
Interest Coverage	2,112.44

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	18.94%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	5.86%
Revenue Per Employee	5.41M
Profits Per Employee	587,710
Employee Count	1,298
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Venus Remedies has paid 273.02 million in taxes.

Income Tax	273.02M
Effective Tax Rate	26.36%

Stock Price Statistics

The stock price has increased by +137.15% in the last 52 weeks. The beta is 0.31, so Venus Remedies's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	+137.15%
50-Day Moving Average	764.54
200-Day Moving Average	541.89
Relative Strength Index (RSI)	47.03
Average Volume (20 Days)	2,419

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Venus Remedies had revenue of INR 7.03 billion and earned 762.85 million in profits. Earnings per share was 57.08.

Revenue	7.03B
Gross Profit	3.31B
Operating Income	959.05M
Pretax Income	1.04B
Net Income	762.85M
EBITDA	1.10B
EBIT	959.05M
Earnings Per Share (EPS)	57.08

Full Income Statement

Balance Sheet

The company has 2.36 billion in cash and 143.80 million in debt, with a net cash position of 2.21 billion or 165.61 per share.

Cash & Cash Equivalents	2.36B
Total Debt	143.80M
Net Cash	2.21B
Net Cash Per Share	165.61
Equity (Book Value)	5.94B
Book Value Per Share	444.63
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 47.04%, with operating and profit margins of 13.65% and 10.85%.

Gross Margin	47.04%
Operating Margin	13.65%
Pretax Margin	14.74%
Profit Margin	10.85%
EBITDA Margin	15.70%
EBIT Margin	13.65%
FCF Margin	n/a

Dividends & Yields

Venus Remedies does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.04%
Shareholder Yield	0.04%
Earnings Yield	7.72%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2